Nachrichten zur Johnson & Johnson Aktie

J&J (JNJ) to Begin Q2 Earnings Season for Drug, Biotech Sector

Growth in J&Js (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex. In the MedTech segment,…

Johnson & Johnson sues Biden administration over Medicare drug price negotiations

Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month....…

J&J sues US govt to halt Medicare drug price negotiation plans

...(Reuters) - Johnson & Johnson sued the U.S. government on Tuesday......…

UPDATE 1-J&J sues US govt to halt Medicare drug price negotiation plans

...(Adds background throughout) July 18 (Reuters) - Johnson & Johnson......…

Earnings week ahead: Tesla, Netflix, Johnson & Johnson, Bank of America and more

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson Poised For A Muted Q2?

We expect the companys revenues to come in at $24.6 billion, marginally below the consensus estimate of $24.7 billion....…

Johnson & Johnson Sues Doctors Over Studies Linking Talc-Based Products and Cancer

Company says the studies played a significant role in lawsuits over its Baby Powder and Shower to Shower products....…

Johnson & Johnson Letting Nonprofit Distribute Life-Saving Generic Tuberculosis Drug—Greatly Expanding Access In Poorer Countries

The drug manufacturer faced an online pressure campaign championed by novelist John Green before the announcement Thursday, which lets Stop…

Johnson & Johnson (JNJ) Reports Next Week: Wall Street Expects Earnings Growth

Johnson & Johnson (JNJ) doesnt possess the right combination of the two key ingredients for a likely earnings beat in…

Is Johnson & Johnson Stock Overvalued?

The stocks premium valuation could be justified....…

FDA classifies J&J electrode recall as most serious type

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jurors urged to impose heavy punitive damages in J&J talc trial

...By Brendan Pierson July 10 (Reuters) - Lawyers for a California man......…

Johnson & Johnson 2Q financial results could beat even as pharma sales weigh

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Johnson & Johnson 2Q results could beat even as pharma sales weigh

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Nanobiotix Shares Soar on Licensing Deal With J&J Unit >NBTX

Nanobiotix Shares Soar on Licensing Deal With J&J Unit >NBTX...…

NANOBIOTIX Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3

PARIS and CAMBRIDGE, Mass., July 10, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the…

Is Johnson & Johnson Stock a Buy Now?

Some businesses never go out of style....…

Is Johnson & Johnson Stock a Buy?

Lets take a look at this Dividend King after its spin-off of Kenvue and its proposed $8.7 billion litigation settlement....…

2 Reasons to Buy Johnson & Johnson, and 1 Reason to Sell

This pharma company has reached an important transition point....…

Bausch + Lomb Buys Blink Eye Drop From J&J for $106.5M

Bausch + Lomb Buys Blink Eye Drop From J&J for $106.5M...…

Protagonist Therapeutics-Janssen Partnered Psoriasis Candidate Fall Short Of Rival Treatment

Protagonist Therapeutics Inc (NASDAQ: PTGX) announced topline results from the Phase 2b FRONTIER 1 trial of the oral interleukin-23 receptor (IL-23R)…

Protagonist Therapeutics, Inc.: Protagonist Therapeutics Announces Positive Topline Results with JNJ-2113, the First and Only Oral IL-23 Receptor Antagonist Peptide in Development for Moderate-to-Severe Plaque Psoriasis

Phase 2b FRONTIER 1 data presentation at World Congress of Dermatology highlights that a greater proportion of patients achieved 75,…

Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know

Johnson & Johnson (JNJ) closed at $163.35 in the latest trading session, marking a -1.31% move from the prior day....…

Johnson & Johnson psoriasis pill disappoints in phase 2 trial

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

J&J Fights to Save Legal Strategy That Would End Cancer Lawsuits

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Check Out What Whales Are Doing With JNJ

Johnson & Johnson: Langfristig interessant - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär": Jürgen Dreifürst vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die…

Is Johnson & Johnson Stock a Strong Buy?

The healthcare giant should deliver strong returns for shareholders over the long term....…

Where Will Johnson & Johnson Be in 5 Years?

The stocks returns over the past decade havent been great -- should investors expect that to change?...…

Biden Admin Stiffing COVID Vaccine-Injured Americans Over Medical Claims

Biden Admin Stiffing COVID Vaccine-Injured Americans Over Medical Claims …

Appia Bio Expands Leadership Team With Sylvaine Cases, Ph.D. Appointed Chief Business Officer and Alex Babayan, Ph.D. as Vice President, Head of Regulatory Affairs

Dr. Cases is a proven life sciences leader with more than 20 years business development and R&D experience including Johnson…

SonoThera™ Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer

Zimmermann brings more than two decades of experience in business development, merger and acquisition strategy, deals and partnership development. Prior…

California man tells jury of getting cancer after using J&J baby powder

...By Brendan Pierson June 26 (Reuters) - A California man suing Johnson......…

Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know

Johnson & Johnson (JNJ) closed the most recent trading day at $163.63, moving -1.12% from the previous trading session....…

Dow falls 109 points on losses for Amgen, Johnson & Johnson shares

Dow falls 109 points on losses for Amgen, Johnson & Johnson shares...…

J&J talc bankruptcy unit to establish $750M trust fund with insurers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Cramer says J&J stock is a coiled spring

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET....…

Will Johnson & Johnson Be a Trillion-Dollar Stock by 2038?

The healthcare company is already almost halfway there....…

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…

Immix Biopharma Subsidiary Nexcella Appoints Mary Sue Coleman, former Johnson & Johnson Independent Director, to Board of Directors

Um den gesamten Artikel unter globenewswire.com zu lesen, klicken Sie bitte auf die Überschrift...…

dpa-AFX ProFeed